Document:

QuickLinks
 -- Click here to rapidly navigate through this document

EXHIBIT 4.2  

 
 

AMENDED AND RESTATED
  BYLAWS
  OF
  INNOVEX, INC.    
    

ARTICLE I 

Shareholders  

        Section 1.    The shareholders of this corporation shall hold an annual meeting in each calendar year at such time and
place, within or without the State of Minnesota, as may be designated by the Board of Directors, provided, however, that the interval between two consecutive annual meetings shall not be more than
fourteen (14) months nor less than ten (10) months. A notice setting out the time and place of the annual meeting shall be mailed by the secretary of the corporation, or his delegate,
postage prepaid, to each shareholder of record at his address as it appears on the records of the corporation, or, if no such address appears, at his last known place of residence, at least ten
(10) days prior to said annual meeting, but any shareholder may waive such annual notice by a signed waiver in writing. 

        Section 2.    At the annual meeting the shareholders shall elect directors of the corporation and shall transact such
other business as may come before them. 

        Section 3.    A special meeting of the shareholders may be called at any time by the president, and shall be called by
the president or the secretary upon the request in writing, or by vote of, one third of the directors or upon the request in writing of shareholders of record owning one-fourth of
the outstanding shares of common stock. Such meeting shall be called by mailing a notice thereof as above provided in the case of the annual meeting of shareholders, which notice shall state the
purpose or purposes of the meeting. 

        Section 4.    At any shareholders' meeting, each shareholder shall be entitled to one (1) vote for each share of
common stock standing in his name on the books of the corporation as of the date of the meeting. Any shareholder may vote either in person or by proxy. The presence in person or by proxy of the
holders of a majority of the shares of common stock entitled to vote at any shareholders' meeting shall constitute a quorum for the transaction of business. If no quorum be present at any meeting, the
shareholders present in person or by proxy may adjourn the meeting to such future time as they shall agree upon without further notice other than by announcement at the meeting at which such
adjournment is taken. 

ARTICLE II 

Directors  

        Section 1.    The Board of Directors shall have the general management and control of all business and affairs of the
corporation and shall exercise all the powers that may be exercised or performed by the corporation under the statutes, its Articles of Incorporation and its Bylaws. 

        Section 2.    The Board of Directors of this corporation shall consist of eight (8) directors. This number may be
increased by the Board of Directors and additional directors elected by the existing Board of Directors, without approval by the shareholders; but this number shall only be decreased by the
shareholders. 

        Section 3.    The term of office of each director shall extend from the annual meeting of shareholders at which he was
elected until the next annual meeting. 

 

        Section 4.    If a vacancy or vacancies in the Board of Directors occur for any reason, such vacancy or vacancies may be
filled, until the next annual meeting of shareholders, by a vote of a majority of the remaining directors. 

        Section 5.    The Board of Directors may meet regularly at such time and place as it shall fix by resolution, and no
notice of regular meetings shall be required. Special meetings of the Board of Directors may be called by the Chairman of the Board, the president or by any two (2) directors by giving at least
twenty-four (24) hours' notice to each of the other directors by mail, telephone, telegraph, or in person. 

        Section 6.    A majority of the directors shall constitute a quorum for the transaction of business. Any act which might
have been taken at a meeting of the Board of Directors may be taken without a meeting if authorized in a writing signed by all of the directors, any such action shall be as valid and effective in all
respects as if taken by the Board at a regular meeting. 

        Section 7.    The Board of Directors shall fix and change, as it may from time to time determine, the compensation to be
paid the president, and may fix and change, as it may from time to time determine, the compensation to be paid the other officers of the corporation. 

        Section 8.    The Board of Directors may designate two (2) or more of their number to constitute an Executive
Committee which, to the extent determined by the Board, shall have and exercise the authority of the Board in the management of the business of the corporation. Such Executive Committee shall act only
in the interval between meetings of the Board and shall be subject at all times to the control and direction of the Board. 

ARTICLE III 

Officers  

        Section 1.    The officers of this corporation shall be a president, a treasurer, a secretary and such vice presidents
and other officers as may from time to time be elected by the Board of Directors. If a Chairman of the Board of Directors is elected, he shall have the status of an officer of the corporation. All
officers shall be elected by the Board of Directors and shall serve at the pleasure of the Board of Directors. Any two (2) of the offices except those of the president and vice president may be
held by the same person. 

        Section 2.    The president may fix and change, as he may from time to time determine, the compensation to be paid the
officers, other than the president, and the employees of the corporation, subject to the power of the directors to fix and change the compensation of the officers. 

        Section 3.    The vice president, or first vice president if there is more than one, shall perform the duties and assume
the responsibilities of the president in the absence or inability to act of the president. In case of the death, resignation or permanent disability of the president, the vice president shall act as
president until the Board of Directors designates such new president. 

        Section 4.    The secretary shall keep a record of the minutes of the proceedings of meetings of directors and of
shareholders, have custody of the corporate seal and shall give notice of such meetings as required in these Bylaws or by the Board of Directors. 

        Section 5.    The treasurer shall keep accounts of all monies and other assets of the corporation received or disbursed,
shall deposit all monies and valuables in the name of and to the credit of the corporation in such banks or depositories or with such custodians as may be authorized to receive the same by these
Bylaws and by the Board of Directors, and shall render such accounts thereof as may be required by the Board of Directors, the president or the shareholders. 

2

 

        Section 6.    The Chairman of the Board of Directors, or the president if there be no Chairman, shall preside at all
meetings of the Board of Directors and of the shareholders, shall make such reports to the Board and the shareholders as may from time to time be required of him and shall have such other powers and
perform such other duties as are incident to his office or as may be from time to time assigned to him by the Board of Directors. 

ARTICLE IV 

Office  

        The principal office of the corporation shall be in the City of Minneapolis in the State of Minnesota. The corporation may also have an office or offices in such
other places and in such other states as the Board of Directors may from time to time authorize and establish. 

ARTICLE V 

Seal; Stock Certificates  

        Section 1.    The corporate seal of the corporation shall consist of the name of the corporation and the name of the
state of incorporation and shall be in such form and bear such other inscription as the Board of Directors may determine. 

        Section 2.    Stock certificates issued by the corporation shall be signed by any two (2) officers. When a
certificate is signed by a transfer agent or registrar, the signature of any such officer and the corporate seal may be facsimiled, engraved or printed. 

ARTICLE VI 

Closing of Stock Records of

Fixing of Record Date  

        The Board of Directors shall have power to close the stock records of the corporation for a period not to exceed sixty (60) days preceding the date of any
meeting of shareholders, or the date for payment of any dividend, or the date for the allotment of rights, or the date when any change or conversion or exchange of capital stock shall go into effect,
or for a period of not exceeding sixty (60) days in connection with obtaining the consent of the shareholders for any purpose; provided, however, that in lieu of closing the stock records, the
Board of Directors may fix in advance a date not exceeding sixty (60) days preceding the date of any meeting of shareholders, or the date for the payment of any dividend, or the date for the
allotment of rights, or the date when any change or conversion or exchange of capital stock shall go into effect, or a date in connection with obtaining such consent of shareholders, as a record date
for the determination of the shareholders entitled to receive notice of and to attend such meeting of shareholders, or for the determination of shareholders entitled to receive payment of any such
dividend or to receive any such allotment of rights or to exercise rights in respect of any such change, conversion or exchange of capital stock, or to give any such consent, as the case may be, and
in such case only such shareholders as shall be shareholders of record on the date so fixed shall be entitled to such notice of and to attend such meeting, or to receive payment of such dividend, or
to receive such allotment of rights, or to exercise any rights, or to give such consent, as the case may be, notwithstanding the transfer of any stock on the books of the corporation after any such
record date fixed as aforesaid. 

3

 

ARTICLE VII 

Indemnification  

        Section 1.    The corporation shall indemnify any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding, wherever brought, whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation, by
reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation, as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys' fees, judgments, fines and amounts paid in settlement actually and reasonably
incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably
believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The
termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, shall not,
of itself, create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation and, with
respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful. 

        Section 2.    The corporation shall indemnify any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director or officer of another
corporation, or is or was serving at the request of the corporation as director or officer of another corporation, partnership, joint venture, trust or other enterprise against expenses (including
attorneys' fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in
or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be
liable for negligence or misconduct in the performance of his duty to the corporation unless and only to the extent that the District Court of the State of Minnesota or the court in which such action
or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to
indemnity for such expenses which the District Court of the State of Minnesota or such other court shall deem proper. 

        Section 3.    To the extent that any person referred to in Sections 1 and 2 of this Article VII has been
successful on the merits or otherwise in defense of any action, suit or proceeding referred to herein or in defense of any claim, issue or matter therein, he shall be indemnified against expenses
(including attorneys' fees) actually and reasonably incurred by him in connection therewith. 

        Section 4.    Any indemnification under Sections 1 and 2 of this Article VII (unless ordered by a court) shall be
made by the corporation, only as authorized in the specific case upon a determination that indemnification of the director or officer is proper in the circumstances because he has met the applicable
standard of conduct set forth in Sections 1 and 2 of this Article VII. Such determination shall be made (i) by the Board of Directors by a majority vote of a quorum consisting of
directors who were not parties to such action, suit or proceeding, or (ii) if such quorum is not obtainable, or even if obtainable, a quorum of disinterested directors so directs, by
independent legal counsel in a written opinion, or (iii) by the stockholders. 

        Section 5.    Expenses incurred in defending a civil or criminal action, suit or proceeding may be paid by the
corporation in advance of the final disposition of such action, suit or proceeding as authorized by the Board of Directors in the specific case upon receipt of an undertaking by or on 

4

 

behalf
of the director or officer to repay such amount unless it shall ultimately be determined that he is entitled to be indemnified by the corporation as provided in this Article VII. 

        Section 6.    The indemnification provided by this Article VII shall not be deemed exclusive of any other rights
to which those seeking indemnification may be entitled under any statutes, bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity
and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and
administrators of such a person. 

        Section 7.    The corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the corporation would have
the power to indemnify him against such liability under the provisions of this Article VII. 

        Section 8.    The Board of Directors may, by resolution, extend the indemnification provisions of the foregoing
Article VII to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding by reason of the fact that he is or was an
employee or agent of the corporation, or is or was serving at the request of the corporation as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. 

ARTICLE VIII 

Indemnification of Corporation  

        Any payment made to an officer of the corporation such as salary, commission, bonus, interest or rent, or entertainment expense incurred by him, which shall be
disallowed in whole or in part as a deductible expense by the Internal Revenue Service shall be reimbursed by such officer to the corporation to the full extent of such disallowance. It shall be the
duty of the directors, as a Board, to enforce payment of such amount disallowed. In lieu of payment by the officer, subject to the determination of the directors, proportionate amounts may be withheld
from his future compensation payments until the amount owed to the corporation has been recovered. 

ARTICLE IX 

Adoption and Amendment of Bylaws  

        Section 1.    The Board of Directors may alter or amend these Bylaws and may make or adopt additional Bylaws subject to
the power of the shareholders to change or repeal the Bylaws, except that the Board of Directors shall not make or alter any Bylaws fixing their qualifications, classifications or term of office, or
reducing their number. 

        Section 2.    The shareholders may alter or amend these Bylaws and may make or adopt additional Bylaws by a majority vote
at any annual meeting of the shareholders or at any special meeting called for that purpose. 

5

QuickLinks

AMENDED AND RESTATED BYLAWS OF INNOVEX, INC.QuickLinks
 -- Click here to rapidly navigate through this document

 
 

EXHIBIT 10.1    
    

CERTAIN
INFORMATION HAS BEEN DELETED FROM THIS EXHIBIT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 406. 

 
 

LICENSE AND DEVELOPMENT
  AGREEMENT    
    

        THIS AGREEMENT, entered into as of this 12th day of October, 1999, by and between INNOVEX PRECISION COMPONENTS, INC. ("IPC"), a Minnesota corporation and
wholly-owned subsidiary of Innovex, Inc. ("Innovex") and APPLIED KINETICS, INC., a Minnesota corporation ("AKI"). 

WITNESSETH:  

        WHEREAS, on January 16, 1998 Litchfield Precision Components, Inc., a wholly-owned subsidiary of
Innovex ("LPC") and AKI entered into a Product Development Contract (the "Current Contract") pursuant to which AKI developed certain proprietary technology necessary to build a machine that attaches
flexible circuits onto disk drive suspension assemblies (the "AFAM Technology"); and 

        WHEREAS, AKI has protected certain elements of the AFAM Technology with patent filings with the United States Patent and Trademark Office
and the remaining elements of the AFAM Technology are protected as trade secrets; and 

        WHEREAS, using the AFAM Technology, AKI designed and built an automated flexible circuit attach machine (the "AFAM") a number of which
have since been delivered to, tested and accepted by IPC; and 

        WHEREAS, during the course of IPC's FSA product development, IPC has developed and owns certain damping devices that exhibit low gain when
compared to state of the art devices (the "Damping Technology"); and 

        WHEREAS, the Current Contract requires AKI, during the "Term" of the Current Contract, to build or have built additional AFAMs for
IPC on a mutually acceptable schedule to use in the course of its business; and 

        WHEREAS, all additional AFAMs delivered by AKI to IPC during the Term of the Current Contract (i.e., through January 15,
2000) are sold to IPC at AKI's actual cost as set forth in the Current Contract; and 

        WHEREAS, as compensation for the development efforts of AKI, and for AKI's agreement to sell additional AFAMs to IPC at cost, IPC
is required to pay AKI a development fee through the end of the Term of the Current Contract of $55,500 per month; and 

        WHEREAS, in consideration of the payment of the development fee, AKI has licensed IPC the right to use the AFAM Technology solely to allow
IPC to use the AFAMs for their intended purpose of placing flexible circuits onto disk drive suspensions; the right to produce FSA product on AFAMs; and the right to transfer AFAMs and
FSA products produced on AFAMs to customers of IPC solely for use by such customers; and 

        WHEREAS, AKI and IPC are parties, together with Hutchinson Technology Incorporated, Innovex, Ryan Jurgenson, Mark Girard, David Swift,
Roger Livermore and Joseph Tracy to a Settlement Agreement dated as of April, 19, 1999 (the "Settlement Agreement") pursuant to which AKI is restricted, until January 16, 2000, from engaging in
certain design and promotion activities as more particularly set forth in the Settlement Agreement; and 

        WHEREAS, recognizing the potential for AFAMs, IPC and AKI desire to expand and extend their contractual relationship effective after
January 16, 2000 and, accordingly, this Agreement is entered 

 

into
as of the date first set forth above but is not intended to be, and shall not be, effective until January 17, 2000 (the "Effective Date"); and 

        WHEREAS, IPC desires, after the Effective Date, to: a) obtain the right to purchase additional AFAMs from AKI at cost for
nine (9) years, b) obtain the right to use AFAMs for their intended purpose of placing flexible circuits onto disk drive suspensions, the right to produce FSA (as hereafter
defined) product and other goods on AFAMs, and the right to sell FSA product and other goods to customers in the ordinary course of business, c) obtain the right to transfer AFAMs to
customers of IPC solely for use by such customers to produce FSA product, d) obtain AKI's covenant not to sell AFAMs to third parties for nine (9) years without IPC's consent,
e) obtain certain license rights to the AFAM Technology for twelve (12) years sufficient to have AFAMs made by parties other than AKI and to sublicense this right to customers of
IPC (so that such customers have the right to have AFAMs made by their own equipment manufacturer), f) obtain certain commitments from AKI for nine (9) years with respect to
designing modifications and improvements to the AFAM, g) obtain rights, in the field of disk drive suspensions and suspension components (the "Suspension Field"), to the results of any product
design done by AKI which rights will be exclusive for nine (9) years and non-exclusive for three (3) years thereafter, and h) obtain certain rights to Microactuation
Technology (as hereinafter defined) as may be developed by AKI; all as more fully set forth hereinafter; and 

        WHEREAS, AKI is willing to grant the above-described rights in exchange for certain royalty payments commencing after the Effective Date
and continuing for twelve (12) years all on the terms and conditions set forth in this Agreement; 

        NOW, THEREFORE, in consideration of the foregoing premises, and for good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, it is hereby agreed as follows: 

 
 

ARTICLE I
  RECITALS    
    

        1.1    Incorporation.    The foregoing recitals are incorporated into this Agreement. 

 
 

ARTICLE II
  SALE OF AFAMS TO IPC    
    

        2.1    Sale of AFAMs.    Subject to AKI and IPC agreeing on the quantity and delivery schedule of AFAMs (such
agreement to be evidenced by purchase orders submitted by IPC and accepted in writing by AKI), AKI agrees, for a period of nine (9) years from and after the Effective Date, to manufacture and
sell such agreed upon AFAMs to IPC at AKI's actual cost of Material (plus all transportation and shipping costs) taking into account previous reimbursement or direct purchase by IPC of
Material. For purposes of this Agreement, Material shall mean all parts, components, other direct supplies, and services contracted for by AKI with unrelated third parties related exclusively to
manufacture of AFAMs and out of pocket expenses directly related thereto. IPC shall have the right to sell or otherwise transfer AFAMs subject to the provisions of Section 3.1 and
3.2 hereof; and on the condition that IPC be solely responsible for complying with all export control laws, rules and regulations. 

        2.2    Warranties of AKI.    AKI hereby assigns, to the extent permitted by the terms thereof, to IPC, all warranties
obtained by or running in favor of AKI relating to AFAMs (including parts and components thereof). AKI agrees to assist, at IPC's expense, IPC in pursuing any claim under such warranties or, in
the event that any such warranties are not assignable by AKI to IPC, then AKI agrees to pursue, for the account of and at the expense of IPC, warranty claims as directed by IPC. EXCEPT AS PROVIDED IN
THIS AGREEMENT, NO OTHER REPRESENTATIONS OR WARRANTIES OF ANY TYPE OR KIND, EITHER EXPRESS OR IMPLIED, ARE MADE WITH RESPECT TO AFAMS SOLD TO IPC (INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF 

2

 

PERFORMANCE,
QUALITY, NON-INFRINGEMENT, CONDITION, OR DURABILITY) AND ALL SUCH WARRANTIES, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, ARE
HEREBY DISCLAIMED. 

        2.3    Restriction on AKI Sale of AFAMs and AFAM Technology.    AKI agrees, for a period of nine (9) years from
the Effective Date, that it will not sell, lease, license, or otherwise transfer AFAMs or AFAM Technology to any person or entity without the express written consent of IPC; provided, however,
that IPC acknowledges that the foregoing restriction does not apply to any use of AFAM Technology by AKI for development and sale of other products provided that such other products do not incorporate
AFAMs as a subset therein; and provided, further, that the foregoing restrictions shall automatically terminate in the event that IPC elects to discontinue its participation in the disk drive
industry. 

        2.4    AKI Support.    AKI agrees, for nine (9) years from the Effective Date, to support IPC's use and resale
of AFAMs by providing, at IPC's cost and expense, reasonable training of IPC and/or IPC customer personnel relating to operation and maintenance of AFAMs upon reasonable notice and
subject to reasonable availability of AKI personnel. Additionally, for a three (3) year period commencing nine (9) years from the Effective Date, AKI agrees to continue providing the
afore-described services, at IPC's expense, if IPC personnel are not qualified to provide such services. 

 
 

ARTICLE III
  AFAM TECHNOLOGY LICENSE RIGHTS    
    

        3.1    Acknowledgment of Ownership.    IPC hereby acknowledges and agrees that AKI is and shall be the sole owner of
the AFAM Technology including any and all modifications, enhancements, improvements and derivations thereof, whether developed by AKI, IPC, or jointly; and that IPC has no rights therein except as
expressly set forth in this Agreement. 

        3.2    License for Use.    In consideration of the payment of royalties required by this Agreement, AKI hereby grants
to IPC the nonexclusive and perpetual right to use the AFAM Technology solely to use and operate AFAMs for their intended purpose of placing flexible circuits onto disk drive suspensions, the
right to produce FSA product on AFAMs, and the right to transfer AFAMs and FSA products produced on AFAMs to customers of IPC solely for use by such customers. IPC shall have the right
to sublicense the foregoing rights to its customers who acquire an AFAM from IPC or manufacture or have manufactured an AFAM pursuant to the license right contained in Section 3.3 hereof; on
the condition that each sublicense and/or agreement for sale or other transfer of an AFAM be in writing, contain appropriate acknowledgments of the ownership by AKI of the AFAM Technology, require
monthly reporting of the volume of flexible circuit suspension assemblies ("FSAs") produced on each AFAM, permit IPC to audit the books and records of such sublicensee for purposes of verifying the
volume of FSAs produced, and contain appropriate confidentiality provisions. Except as permitted by the preceding sentence, the license rights granted in this Section 3.2 to IPC shall not be
assigned, sublicensed or otherwise transferred by IPC without the prior written consent of AKI; provided, however, that such rights may be transferred in connection with a merger or transfer of all or
substantially all of the assets of IPC provided such transferee assumes all related obligations in writing in form reasonably acceptable to AKI. 

        3.3    Additional License for Use.    In consideration of the payment of royalties required by this Agreement, AKI
hereby grants IPC the nonexclusive and perpetual right to use the AFAM Technology to use AFAMs to produce goods other than FSAs on AFAMs and the right to sell those goods to customers of
IPC in the ordinary course of business. Notwithstanding the foregoing grant, IPC acknowledges that it does not have the right to use AFAMs or AFAM Technology for production of goods comprising
or related to head gimbal assembly or for any other purposes involving head gimbal 

3

 

assembly.
The License rights granted in this Section 3.3 shall not be assigned, sublicensed or otherwise transferred by IPC without the prior written consent of AKI; provided, however, that
such rights may be transferred in connection with a merger or transfer of all or substantially all of the assets of IPC provided such transferee assumes all related obligations in writing in form
reasonably acceptable to AKI. 

        3.4    License to Manufacture.    In consideration of the payment of royalties required by this Agreement, AKI hereby
grants to IPC the nonexclusive right, for twelve (12) years from the Effective Date, to use the AFAM Technology solely for the purpose of manufacturing AFAMs or having
AFAMs manufactured for IPC on the condition that any contract for the manufacture of AFAMs be in writing, contain appropriate acknowledgments of AKI's rights in the AFAM Technology,
require monthly reporting of the volume of FSAs produced on each AFAM retained or used by or for any such manufacturer, permit IPC to audit the books and records of any such manufacturer for purposes
of verifying the volume of FSAs produced, and contain appropriate confidentiality provisions. IPC shall have the right to sublicense the foregoing right to its customers on the condition that any
sublicense be in writing, contain appropriate acknowledgments of the ownership by AKI of the AFAM Technology, require monthly reporting of the volume of FSAs produced by each AFAM manufactured by or
for any such customer, permit IPC to audit the books and records of any such customers for purposes of verifying the volume of FSAs produced, contain appropriate confidentiality provisions, and
require the customer's contract with its equipment manufacturer to meet the requirements imposed on IPC as set forth in the first sentence of this Section 3.3. Except as permitted by the
preceding sentence, the license rights granted in this Section 3.3 to IPC shall not be assigned, sublicensed or otherwise transferred by IPC without the prior written consent of AKI; provided,
however, that such rights may be transferred in connection with a merger or transfer of all or substantially all of the assets of IPC provided such transferee assumes all related obligations in
writing in form reasonably acceptable to AKI. 

        3.5    Certain Contract Requirements.    Whenever IPC enters into an agreement with any third party, or a customer of
IPC enters into an agreement with its equipment manufacturer, which agreement is subject to the requirements of Section 3.2 or 3.3 above, or 4.6 below, IPC shall provide AKI with a copy of such
agreement (and all other documents or agreements related thereto or to be entered into contemporaneously) within ten (10) days of execution. AKI shall have the right, throughout the duration of
this Agreement, to require all sublicenses between IPC and its customers and all agreements for manufacture of AFAMs (whether entered into by IPC or its customers) to contain additional
provisions reasonably necessary or appropriate to protect AKI's rights under this Agreement. Upon written notice from AKI of any such additional provision(s), IPC shall include (or require, as the
case may be) any such provision(s) in its subsequent sublicense agreements and agreements for manufacture of AFAMs, as provided below. In the event that IPC disputes the need or appropriateness of any
such newly requested provision(s), such provision(s) shall nevertheless be incorporated into any sublicense agreements and/or agreements for manufacture of AFAMs entered into after IPC's
receipt of written notice from AKI, and the following procedure shall apply: 

        3.5.1        The parties shall meet, at least twice, during the next thirty (30) days in an
attempt to resolve their differences as to the need or appropriateness of any newly required provision(s). 

        3.5.2        If the newly required provision(s) remains in dispute, the parties shall proceed to
arbitration of the issue in front of an independent patent attorney with at least ten (10) years experience mutually acceptable to both parties. If the parties are unable to agree on the
arbitrator, both parties hereby authorize the Hennepin County, Minnesota Chief Judge, or his or her designee, to appoint an arbitrator meeting the above specified criteria. 

        3.5.3        The arbitrator shall have the power to rule that the disputed provision be included as
drafted by AKI, be stricken, or to modify the provision; but shall not have the power to modify or strike any provisions originally required in this Agreement or required by AKI subsequent to the 

4

 

Effective
Date and not disputed by IPC; nor shall the arbitrator have the power to change any provision of this Agreement. 

        3.5.4        The decision of the arbitrator shall be final and the disputed provision shall thereafter
be continued, be continued as modified, or stricken, as ruled by the arbitrator. Each party shall bear their own costs and expenses related to the arbitration; and the fees of the arbitrator shall be
split equally between the parties. 

 
 

ARTICLE IV
  AFAM IMPROVEMENT AND PRODUCT DEVELOPMENT    
    

        4.1    AFAM Improvement.    Subject to Unavoidable Delays and satisfactory performance by IPC of its obligations under
Section 4.2 hereof, AKI agrees, for nine (9) years from the Effective Date, to use commercially reasonable efforts to make modifications, improvements and/or enhancements to
AFAMs (collectively "AFAM Improvements") that AKI and IPC mutually agree have a reasonable possibility of commercial application. AKI and IPC agree to have at least quarterly meetings (a
"Development Meeting") for purposes of discussing possible AFAM Improvements. 

        4.2    Responsibility for AFAM Improvement Costs.    IPC agrees, during the nine (9) year period commencing on
the Effective Date, to pay for all costs and expenses of the development of mutually agreed upon AFAM Improvements which costs may include parts, components, other direct supplies, services contracted
for by AKI with unrelated third parties related exclusively to development of AFAM Improvements and out of pocket expenses directly related thereto; but shall not include patent application and
maintenance fees and associated legal expenses. 

        4.3    Ownership of Intellectual Property.    IPC hereby acknowledges and agrees that AKI is and shall be the sole
owner of all intellectual property rights associated with AFAM Improvements, whether developed by AKI, IPC, or jointly; and any other intellectual property rights generated as a result of the
development work being done by AKI under this Agreement; and that IPC has no rights therein except as expressly set forth in this Agreement. Notwithstanding the foregoing, the license rights contained
in Sections 3.2 and 3.3 hereinabove shall apply to all AFAM Improvements on the same basis as such license rights apply to AFAM Technology. 

        4.4    Product Design.    Subject to Unavoidable Delays and satisfactory performance by IPC of its obligations under
Section 4.5 hereof, AKI agrees to use commercially reasonable efforts to design modifications, improvements and/or enhancements to products that are designed to be produced on
AFAMs ("FSA Product Improvements") which AKI and IPC mutually agree have a reasonable possibility of commercial application. Ideas for FSA Product Improvements shall be discussed by the parties
at each Development Meeting in conjunction with discussions of AFAM Improvements. 

        4.5    Responsibility for FSA Product Improvement Cost and Expenses.    IPC agrees, during the nine (9) year
period commencing on the Effective Date, to pay for all costs and expenses of the development of mutually agreed upon FSA Product Improvements, which costs may include parts, components, software
licensing fees sufficient to allow AKI to use software necessary to perform its development obligations under this Agreement and for no other purpose for nine (9) years from the Effective Date,
other direct supplies, services contracted for by AKI with unrelated third parties related exclusively to development of FSA Product Improvements, and out of pocket expenses directly related thereto;
but shall not include patent application and maintenance fees and associated legal expenses if AKI is the sole owner of the intellectual property rights arising therefrom. 

        4.6    Ownership of FSA Product Improvement Intellectual Property.    IPC hereby acknowledges and agrees that AKI is
and shall be the sole owner of all intellectual property rights associated with FSA Product Improvements and any other intellectual property rights independently invented by AKI as a result of the
development work being done by AKI under this Agreement. Notwithstanding the 

5

 

foregoing,
in consideration of the payment of royalties required by this Agreement, AKI hereby grants to IPC the right to use the FSA Product Improvements for twelve (12) years from the
Effective Date solely in the Suspension Field. Such license rights shall be exclusive for nine (9) years from the Effective Date and shall be nonexclusive for three (3) years thereafter.
IPC shall have the right to sublicense the rights granted in this Section 4.6 solely to customers owning or using AFAMs provided such sublicense agreements be in writing, contain
appropriate acknowledgments of the intellectual property rights of AKI to FSA Product Improvements, require monthly reporting of the volume of FSAs produced on each AFAM owned or used by or for such
customers, permit IPC to audit the books and records of any such customers for purposes of verifying the volume of FSAs produced and contain appropriate confidentiality provisions. Except as permitted
by the preceding sentence, the license rights granted in this Section 4.6 to IPC shall not be assigned, sublicensed or otherwise transferred by IPC without the prior written consent of AKI;
provided, however, that such rights may be transferred in connection with a merger or transfer of all or substantially all of the assets of IPC provided such transferee assumes all related obligations
in writing in form reasonably acceptable to AKI. In the event that AKI and IPC jointly invent FSA Product Improvements, AKI and IPC shall jointly own any such FSA Product Improvements; and the license
granted hereinabove in this Section 4.6 by AKI to IPC shall apply to AKI's rights in such jointly invented FSA Product Improvements on the same basis as if AKI had independently invented such
FSA Product Improvements. AKI hereby acknowledges and agrees that IPC is and shall be the sole owner of all intellectual property rights associated with FSA Product Improvements and any other
intellectual property rights independently invented by IPC, other than intellectual property rights related to AFAM Technology and AFAM Improvements. 

 
 

ARTICLE V
  MICROACTUATION    
    

        5.1    Acknowledgment of Ownership.    IPC hereby acknowledges that AKI may develop certain technology related to dual
stage actuated suspensions or suspensions that accept such actuators (hereinafter "Microactuation Technology") and that AKI is and shall be the sole owner of Microactuation Technology developed by AKI
including any and all modifications, enhancements, improvements and derivations thereof. Notwithstanding the foregoing, in consideration of the payment of royalties required by this Agreement, AKI
hereby grants to IPC the right to use Microactuation Technology for twelve (12) years from the Effective Date solely in the Suspension Field. Such license right shall be exclusive for nine
(9) years from the Effective Date and shall be nonexclusive for three (3) years thereafter. Subject to the obligation of IPC to share revenues with AKI as set forth in Section 5.2
hereof, IPC shall have the right to sublicense the rights granted in this Section 5.1 provided such sublicense agreements be in writing, contain appropriate acknowledgments of the intellectual
property rights of AKI to Microactuation Technology, require periodic reporting of field of use and revenue received from use of Microactuation Technology, permit IPC to audit the books and records of
any such sublicensees for purposes of verifying royalty obligations owed to IPC, contain appropriate confidentiality provisions, and be otherwise in form reasonably acceptable to AKI. Additionally,
IPC agrees that AKI shall have the right to be represented in the negotiations with any proposed sublicensee. Except as permitted by the preceding two sentences, the license rights granted in this
Section 5.1 to IPC shall not be assigned, sublicensed or otherwise transferred by IPC without the prior written consent of AKI; provided, however, that such rights may be transferred in
connection with a merger or transfer of all or substantially all of the assets of IPC provided such transferee assumes all related obligations in writing in form reasonably acceptable to AKI. 

        5.2    Revenue Sharing.    In consideration of the right granted to IPC to sublicense its rights to Microactuation
Technology, IPC hereby agrees to pay to AKI, as and when received, [* * *] of all Net Revenue received by IPC as a result of making IPC's rights in Microactuation
Technology available to any third party. For purposes of this Agreement "Net Revenue" means all revenue received by IPC for making Microactuation Technology available to any third party, without any
deductions or offsets, 

6

 

regardless
of whether revenue is received on a per piece basis, as a general payment or prepayment for intellectual property rights, as a payment for services, is incorporated into the price of
products, as a return on investment, or otherwise; reduced by the cost of obtaining license rights from third parties necessary for the desired sublicensing of Microactuation Technology provided that
AKI has approved the amount of such cost and the form of license agreement in advance, which approval shall not be unreasonably withheld. In the event that IPC receives revenue from any such third
party resulting from the sale or other transfer of goods or the provision of services, an equitable allocation of revenue shall be made between products sold or services provided and the sublicensing
or other transfer of IPC's rights in Microactuation Technology. 

 
 

ARTICLE VI
  ROYALTY PAYMENTS    
    

        6.1    General Payment Obligation.    In consideration of: the licenses granted to IPC under this Agreement to AFAM
Technology, AFAM Improvements, FSA Product Improvements and Microactuation Technology, the obligation to sell AFAMs to IPC at AKI's cost, and the above-described commitment to provide services,
and in addition to the payment obligations of IPC set forth in Section 5.2 hereof, IPC agrees to pay AKI, on a monthly basis as set forth in Section 6.3 hereof, for twelve
(12) years from the Effective Date, [* * *] of all FSA Revenue (as hereinafter defined) produced from the operation of each and every AFAM (regardless of
whether an AFAM was purchased from AKI or was manufactured by IPC or any other third party). For purposes of this Agreement, "FSA Revenue" shall mean the total number of FSAs sold by IPC added to the
total number of FSAs produced by all other parties using one or more AFAMs or AFAM Technology multiplied by the FSA Price; "FSA Price" shall mean the weighted average sale price of FSAs sold by
IPC during the preceding one (1) month period; and the "weighted average sale price" shall mean the gross price charged by IPC (without any deductions or offsets and assuming IPC either
purchases or manufactures all of the components of an FSA) for all FSAs sold by IPC during the preceding one (1) month period divided by the total number of FSAs sold by IPC during said one
(1) month period. In the event that IPC discontinues selling FSAs (as evidenced by IPC's volume of FSAs sold dropping below 5% of the total volume of FSAs produced on all AFAMs), the average of
the FSA Price calculated for the most recent three (3) months shall be deemed the FSA Price through the end of the calendar year quarter in which IPC has discontinued or is deemed to have
discontinued selling FSAs. Thereafter and through the end of the period during which royalties are due under this Agreement, the FSA Price shall be adjusted, up or down as the case may be, on a
quarterly basis, by a percentage equal to the percentage increase or decrease in the weighted average sale price of flexible circuits for FSA product for the calendar year quarter just ended over the
weighted average sale price of flexible circuits for the preceding calendar year quarter. For purposes of the preceding sentence, the "weighted average sale price" shall mean the gross price charged
by IPC (without any deductions or offsets and assuming that all consideration paid to IPC for flexible circuits for FSA product—whether or not reflected in the gross sales
price—is included in the calculation) for all flexible circuits for FSA product divided by the total number of flexible circuits for FSA product sold by IPC over the applicable calendar
year quarter. IPC acknowledges that a royalty payment is owed as set forth above as a result of the use of all AFAMs regardless of whether IPC is paid a royalty or other consideration from any
of its customers or other third parties using or owning AFAMs or AFAM Technology. In calculating the number of FSAs sold by IPC, IPC shall have the right to adjust such amount for rejections
and returns of FSAs. 

        6.2    Additional Payment Obligation.    In consideration of: the licenses granted to IPC under this Agreement to AFAM
Technology, AFAM Improvements, FSA Product Improvements and Microactuation Technology, the obligation to sell AFAMs to IPC at AKI's cost, and the above-described commitment to provide services,
and in addition to the payment obligations of IPC set forth in Section 5.2 and 6.1 hereof, IPC agrees to pay AKI, on a monthly basis as set forth in Section 6.3 

7

 

hereof,
for twelve (12) years from the Effective Date, [* * *] of all Other Product Revenue (as hereafter defined) produced from the operation of each and
every AFAM (regardless of whether an AFAM was purchased from AKI or was manufactured by IPC or any third party). For purposes of this Agreement, "Other Product Revenue" shall mean all revenue received
by IPC from sales or other dispositions of products produced on AFAMs pursuant to the license granted in Section 3.3 hereof, without any deductions or offsets, regardless of whether
revenue is received on a per piece basis, as a general payment or prepayment for products in bulk, as a payment for services, is incorporated into the price of other products, as a return on
investment, or otherwise. In the event that IPC receives revenue from any third party resulting from the sale or other disposition of goods or the provision of services, an equitable allocation of
revenue shall be made between the products giving rise to a royalty under this Section 6.2 and such other goods or services. 

        6.3    Monthly Payments.    IPC shall make royalty payments no later than the 20th day of each month
during the term of this Agreement, with the first payment being made on or before January 20, 2000, and on the same day of each and every month thereafter up to and including
December 20, 2012. IPC agrees that each of the first twenty-four (24) monthly payments will be at least Sixty Thousand Five Hundred Dollars ($60,500) regardless of the amount
of FSA Revenue generated by AFAM operation. Upon IPC having made the first twenty-four (24) required monthly payments, in the event that the aggregate amount paid by IPC exceeds the
aggregate amount IPC would have paid under Section 6.1 above but for the guaranteed minimum requirement (the "Shortfall") IPC shall have the right to offset against the next six
(6) monthly payments, for application to the Shortfall, that portion, if any, of the monthly royalty payment in excess of $60,500. After said six (6) monthly payments have been made, and
in the event that any Shortfall remains, IPC shall have the right to fully offset against the remaining payments required under Section 6.1 above, for application to the Shortfall, until the
Shortfall has been repaid in full. It is agreed by the parties that no interest shall be charged on the Shortfall. In the event that royalty payments to which AKI is entitled during the twelve
(12) year royalty term are not sufficient to repay the Shortfall by the end of the twelve (12) year term, AKI shall have no further obligation to repay the Shortfall. 

        6.4    Certain Payment Provisions.    Within twenty (20) days after the end of each calendar month during the
term of this Agreement, IPC shall send AKI a written report, itemizing the volume of FSAs or other products sold by IPC on each AFAM owned or used by IPC and the volume of FSAs produced by all other
parties using one or more AFAMs in each case itemized by owner and user of AFAMs, stating the FSA Price or applicable price of other products, calculating the amount of royalty due under
Section 6.1 and/or Section 6.2, identifying the amount of revenue sharing required under Section 5.2 hereof, and providing such further itemization as AKI reasonably may request.
Payment of the amount due shall accompany each such report. AKI shall have the right, at reasonable times not more often than twice per calendar year, and upon not less than 72 hours' prior
notice, to examine and/or audit (directly or with others' help) all of IPC's books, records, and accounts relating to the subject matter of this Agreement, for the sole purpose of verifying IPC's
reports and payments under this Agreement. Except
as necessary to enforce the terms of this Agreement, AKI agrees to hold any information received in such examination or audit in confidence and to instruct any third party retained by AKI in
connection with such examination or audit to do the same. If any examination or audit by or for AKI reveals a shortfall in payment to AKI for any thirty (30) day period in excess of the greater
of $5,000 or 10% of the amount due, IPC shall pay the reasonable costs and expenses of the examination or audit. In addition, IPC shall promptly remit the amount of any shortfall, whether or not in
excess of such amount. All royalty payments shall be made in United States dollars and in immediately or next day available funds. 

        6.5    Certain Monitoring Provisions.    IPC agrees to include in all of its agreements for: a) sale, lease,
licensing or other disposition of AFAMs and b) permitted sublicensing of those license rights granted IPC by AKI in this Agreement, appropriate provisions requiring owners and users of 

8

 

AFAMs and
sublicensees to account to IPC for volume of FSAs produced on AFAMs and giving IPC the right to examine and audit the books and records of such parties related to operation of
and production from AFAMs, all as more specifically set forth hereinabove. In the event that AKI reasonably believes that any such third party is under-reporting its production of FSAs, AKI shall have
the right to require IPC, at IPC's expense, no more often than twice annually, to conduct such examination and audit, and to make the results thereof available to AKI. In the event that any audit of
any third party reveals substantial under-reporting by any third party of production of FSAs on AFAMs, AKI shall have the right to require IPC to terminate its agreements with such party, or to
otherwise exercise legal rights and/or remedies as mutually agreed to by IPC and AKI. 

 
 

ARTICLE VII
  INTELLECTUAL PROPERTY PROTECTION    
    

        7.1    Enforcement.    A party to this Agreement that has reason to suspect any third party of violating any rights of
AKI or IPC in FSA Technology, AFAM Improvements, AFAM Product Improvements, and/or Microactuation Technology, shall promptly notify the other party hereto and provide that party with all available
information and documentation relating to the suspicion. Upon discovering or being notified of a suspected violation, IPC shall have the right to bring, within a reasonable time, and if IPC so elects
to bring, it shall diligently prosecute, an action against the third party. IPC shall keep AKI informed and shall consult reasonably with AKI regarding the action, but shall have the right to select
its own counsel and to prosecute the action in accordance with the advice of its own counsel; provided, however, that IPC shall not abandon, settle or compromise the action, nor resort to means of
dispute resolution other than litigation, without AKI's prior written consent, which shall not be unreasonably withheld. IPC shall pay all costs and expenses of the action and all fees and expenses of
its own counsel and shall have the right to retain any proceeds of the action or of any settlement or compromise thereof, which constitute an infringement of its rights under this Agreement; provided,
however, that the excess, if any, of any such proceeds received by IPC over the sum of: (i) IPC's
reasonable costs and expenses and (ii) the reasonable fees and expenses of IPC's counsel, shall be deemed FSA Revenue and subject to royalty payments to AKI under this Agreement at the rate set
forth in Section 6.1 hereof. Any proceeds received by IPC which relate to infringement of rights of AKI not licensed to IPC under this Agreement shall be paid to AKI; provided, however, that
AKI acknowledges that IPC shall have no obligation to prosecute any claim relating to rights of AKI not licensed to IPC under this Agreement. AKI shall have the right to intervene in any such action
but shall bear the costs and expenses of doing so, including the fees and expenses of its own counsel. In the event that IPC elects not to bring an action against the third party within a reasonable
time, AKI shall have the right to bring any action it deems appropriate, at its cost and expense. AKI shall have the right to retain any proceeds of the action or settlement or compromise thereof;
provided, however, that in the event that AKI has requested IPC's cooperation and assistance in connection with AKI's prosecution, IPC shall be reimbursed for its out of pocket expenses. The party not
prosecuting the action agrees, at the prosecuting party's expense, to cooperate with, provide reasonable assistance to and to appear as a nominal party and lend its name as necessary to validate any
such action brought by the prosecuting party. 

        7.2    Infringement.    If any third party claims that IPC's activities based upon rights licensed by AKI to IPC on an
exclusive basis under this Agreement infringe any patent or copyright, IPC shall defend any such claim related solely to IPC's exclusive rights hereunder at IPC's sole cost and expense with counsel of
IPC's own choosing, and IPC shall pay the amount of any judgment, settlement or compromise of such proceeding (provided, however, that no settlement or compromise shall be agreed to by IPC without
AKI's prior written consent which shall not be unreasonably withheld) and IPC shall pay any ongoing or future royalty or other required payments necessary to engage in IPC's desired activities.
Notwithstanding the preceding sentence, IPC shall not be obligated to defend any claim of infringement by a third party if AKI has breached the representations or obligations made by it in 

9

 

Section 9.2
hereof. AKI shall have the right to participate in any action at AKI's own expense, through counsel selected by AKI. IPC acknowledges and agrees that in the event that any such
third party claim is successful and IPC becomes obligated to pay damages for past infringement, or royalties or other payments for the ongoing or future right to use the intellectual property rights
of any such third party in order to engage in IPC's desired activities, IPC shall not have the right to reduce or offset against the royalty payments owed AKI under this Agreement. 

 
 

ARTICLE VIII
  CONFIDENTIALITY    
    

        8.1    Except
as otherwise provided herein, each of the parties hereto agrees that it will not use, disclose, reproduce or otherwise make available to any person or entity any:
(a) confidential or proprietary information of the other; (b) trade secrets of the other; or (c) any other information or data of the other which has been designated or is known
to be confidential or proprietary to the other. The foregoing
obligations of confidentiality shall not apply to any information which (i) was, at the time of receipt, otherwise known to a party or any of its representatives, (ii) was, at the time
of receipt, published or otherwise known publicly, (iii) becomes known or available to a party or any of its representatives without a breach of this Agreement from a third party having a legal
right to disclose such information, (iv) becomes part of the public domain without breach of this Agreement by any of the parties hereto, or (v) is required to be disclosed by law or
court order. Each of the parties hereto agrees that if there is a breach of this Article 7 the other party will be irreparably harmed and entitled to seek and obtain temporary and permanent
injunctive relief and such other equitable relief against the continuance of such breach without the requirement of posting a bond or undertaking or proving injury or other condition for relief, in
addition to any other remedies that may be available to the injured party at law or in equity. 

 
 

ARTICLE IX
  REPRESENTATIONS, WARRANTIES AND COVENANTS    
    

        9.1    Authorization and Enforceability.    Each of the parties hereto represents and warrants to the other that it
has all necessary corporate power and authority to enter into this Agreement; that it has taken all corporate actions necessary to authorize the execution, delivery and performance of this Agreement;
and that this Agreement is the valid and legally binding obligation of each of the respective parties fully enforceable in accordance with its terms. 

        9.2    Knowledge of Infringement.    AKI hereby represents to IPC that it is not presently aware of any information
which would reasonably lead it to conclude that any third party has a supportable claim for infringement of the intellectual property rights of such third party, or theft of trade secrets of such
third party, as a result of IPC's intended use of AFAM Technology; except the claim asserted on behalf of the Lemelson Medical, Education and Research Foundation, Limited Partnership pursuant to that
certain letter dated May 26, 1999 a copy of which having previously been provided to IPC. AKI hereby agrees that in the event it receives notice of any claim by any third party that the rights
licensed to IPC pursuant to this Agreement infringe on the rights of any third party, it will promptly provide notice of such claim to IPC; and AKI further agrees, upon request of IPC, to consult with
IPC or its legal counsel to assess intellectual property rights of third parties as those rights may relate to technology licensed to IPC hereunder. 

 
 

ARTICLE X
  DEFAULT AND REMEDIES    
    

        10.1    Upon
the material breach by either party of any of the provisions of this Agreement, and the failure to cure such breach within sixty (60) days of receipt of
written notice from the non-breaching party describing such breach with reasonable specificity (or, if curable, such longer 

10

 

period
as may be necessary to cure those breaches which cannot reasonably be cured within sixty (60) days provided the party in breach commences the action necessary to cure the breach within
such sixty (60) day period and diligently and continuously pursues the appropriate action to cure) then an Event of Default shall be deemed to have occurred. Upon the occurrence of an Event of
Default, the non-breaching party shall have, as its sole and exclusive remedies: a) the right to obtain from the breaching party all of the non-breaching party's losses,
damages, costs and expenses suffered or incurred as a consequence of the breach and b) the right to obtain, where appropriate, whatever equitable relief, including injunction, is available.
Notwithstanding the foregoing, in the event of a breach by a party which is not curable, the non-breaching party may immediately seek appropriate equitable relief, including injunction.
The parties agree, after the occurrence of an Event of Default, to meet at least twice during the next thirty (30) days to attempt to agree on the amount of damages and the manner of payment.
In the event that the parties come to agreement, such agreement shall control. In the event that the parties are unable to come to agreement, the non-breaching party shall have the right
to assert its claim for damages in a court of competent jurisdiction. Notwithstanding the foregoing provisions of this Section 10.1, AKI acknowledges and agrees that it does not have the right
to terminate the license rights of IPC regardless of the breach by IPC of any of the provisions of this Agreement; and IPC acknowledges and agrees that it does not have the right to terminate, reduce
or set off against any of the payments which IPC is required to make to AKI under this Agreement regardless of the breach by AKI of any of the provisions of this Agreement provided, however, that upon
IPC obtaining a final judgment for damages against AKI in a court of competent jurisdiction, IPC shall have the right to set off against payments owed to AKI under this Agreement until payment in full
of the amount of any such final judgment, with applicable interest at the judgment rate. 

 
 

ARTICLE XI
  MISCELLANEOUS    
    

        11.1    Assignment and Delegation.    Except as provided herein, neither party may assign any of its rights, or
delegate any of its duties or obligations, hereunder, without the express prior written consent of the other. 

        11.2    Applicable Law; Jurisdiction.    This Agreement shall be governed by and construed in accordance with the laws
of the State of Minnesota. 

        11.3    Independent Contractors.    The parties are and shall be independent contractors as to one another, and
nothing herein shall be deemed to cause this Agreement to create an agency, partnership, or joint venture between the parties. Except as expressly provided in this Agreement, neither party shall be
liable for any debts, accounts, obligations, or other liabilities of the other to any third party. 

        11.4    Waiver.    All remedies available to either party for one or more breaches by the other party are and shall be
deemed cumulative and may be exercised separately or concurrently without waiver of any other remedies. The failure of either party to take action as a result of or in connection with a breach of this
Agreement by the other shall not be deemed a waiver unless in writing and signed by the party against whom enforcement is sought. 

        11.5    Effect of Agreement.    This Agreement constitutes the entire agreement of the parties hereto with respect to
the subject matter hereof and supersedes all prior representations, proposals, discussions, and communications, whether oral or in writing, with respect thereto. Notwithstanding the foregoing, it is
expressly understood that this Agreement does not supersede or constitute an amendment or replacement of the Current Agreement; but is intended to take effect only upon the expiration of the Current
Agreement. Further, the effectiveness of this Agreement shall not terminate, prejudice or impair any rights either party may have under the Current Agreement which rights are intended to survive the
expiration of the Current Agreement. 

11

 

        11.6    Amendment.    This Agreement may be modified or amended only by a writing signed by the parties hereto. 

        11.7    Severability.    To the extent that any provision of this Agreement shall be determined to be invalid or
unenforceable, the invalid or unenforceable portion shall be deleted from this Agreement, and the validity and enforceability of the remainder of this Agreement shall be unaffected. 

        11.8    Interest.    In the event of a failure by either party to pay any amounts required by this Agreement as and
when due, such unpaid amount shall bear interest from the date which is twenty (20) days after the date such amount was due to be paid at the interest rate of ten percent (10%) per annum. The
parties acknowledge that no interest shall be charged on the Shortfall. 

        11.9    Attorneys' Fees.    If any party hereto incurs legal fees, whether or not an action in instituted, to enforce
the terms of this Agreement or to recover damages or injunctive relief for breach of this Agreement, the successful or prevailing party shall be entitled to reasonable attorneys' fees, expert witness
fees and other costs in addition to its claim for damages. 

        11.10    Trademark and Trade Name.    Notwithstanding any other provision of this Agreement, neither party shall have
the right to use any trademark or trade name of the other without the express prior written approval of the other. 

        11.11    Notice.    Any notice required or permitted to be given under this Agreement shall be deemed to have been
delivered on the date the notice is deposited in the United States mail, certified or registered, postage prepaid, return receipt requested, and addressed as follows: 

	 	 	If to AKI to:	Applied Kinetics, Inc.

1125 Highway 7 West

Hutchinson, MN 55350

Attn: President
	

 	
 	

If to IPC to:	

Innovex, Inc.

530 11th Avenue South

Hopkins, MN 55343

Attn: Timothy S. McIntee

        11.12    Unavoidable Delays.    Notwithstanding any other provision of this Agreement to the contrary, failure in the
performance by either party hereunder shall not be deemed a breach or default under this Agreement when such failure is due to war, insurrection, strike, lockout, riot, flood, earthquake, fire, act of
God, act of the public enemy, epidemic, quarantine restriction, freight embargo, governmental restriction, act or the failure to act of a public or governmental agency or entity, or any other act
outside the reasonable control of the party seeking relief provided, however, that none of the foregoing events or occurrences shall excuse, relieve or delay IPC's obligation to make any payments or
reimbursements which IPC is obligated to pay pursuant to this Agreement. Any extension of time for any such cause shall be limited to the period of delay due to such cause. 

        11.13    Headings.    The headings to the various articles, sections and subsections of this Agreement are for the
convenience of the parties and shall not constitute a part of this Agreement. 

        11.14    Excluded Technology.    IPC acknowledges that AKI has developed and is in the process of refining certain
technology for head gimbal assembly and related to electrostatic discharge protection; and that IPC is obtaining no rights therein pursuant to this Agreement. 

        11.15    Intent of Parties.    It is understood and acknowledged by the parties hereto that this Agreement is not
intended to be inconsistent with any provision of the Settlement Agreement and, in the event that any provision of this Agreement is found to be inconsistent with the Settlement Agreement, the parties
agree to negotiate, in good faith, an amendment to this Agreement which 

12

 

eliminates
the inconsistency but which provides both parties the same rights and privileges as contained in this Agreement. 

        11.16    Acknowledgment of Ownership.    AKI hereby acknowledges and agrees that IPC is and shall be the sole owner of
Damping Technology including any and all modifications, enhancements, improvements and derivations thereof, whether developed by AKI, IPC or jointly; and that AKI has no rights therein. 

        IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written. 

	APPLIED KINETICS, INC.	 	INNOVEX PRECISION COMPONENTS, INC.
	

 	

 	
 	

 	

 
	By	/s/  RYAN JURGENSON      
	 	By	/s/  TIMOTHY S. MCINTEE      

	Its	President
	 	Its	Senior Vice President—Corporate

13

QuickLinks

EXHIBIT 10.1

LICENSE AND DEVELOPMENT AGREEMENT

ARTICLE I RECITALS

ARTICLE II SALE OF AFAMS TO IPC

ARTICLE III AFAM TECHNOLOGY LICENSE RIGHTS

ARTICLE IV AFAM IMPROVEMENT AND PRODUCT DEVELOPMENT

ARTICLE V MICROACTUATION

ARTICLE VI ROYALTY PAYMENTS

ARTICLE VII INTELLECTUAL PROPERTY PROTECTION

ARTICLE VIII CONFIDENTIALITY

ARTICLE IX REPRESENTATIONS, WARRANTIES AND COVENANTS

ARTICLE X DEFAULT AND REMEDIES

ARTICLE XI MISCELLANEOUS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}]]